Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Recombinant Protein / Other Proteins

Recombinant Human TRANK1 Protein, C-His

Catalog #:   YHA39401 Specific References (21) DATASHEET
Applications: ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress
Expression system: E. coli
Accession: O15050
Protein length: Val901-Thr1000
Overview

Catalog No.

YHA39401

Expression system

E. coli

Species

Homo sapiens (Human)

Protein length

Val901-Thr1000

Predicted molecular weight

13.37 kDa

Nature

Recombinant

Endotoxin level

Please contact with the lab for this information.

Purity

>90% as determined by SDS-PAGE.

Accession

O15050

Applications

ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress

Form

Lyophilized

Storage buffer

Lyophilized from a solution in PBS pH 7.4, 0.02% NLS, 1mM EDTA, 4% Trehalose, 1% Mannitol.

Reconstitution

Reconstitute in sterile water for a stock solution. A copy of datasheet will be provided with the products, please refer to it for details.

Shipping

In general, proteins are provided as lyophilized powder/frozen liquid. They are shipped out with dry ice/blue ice unless customers require otherwise.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for one week. Store at -20 to -80°C for twelve months from the date of receipt.

Alternative Names

LBA1, TPR and ankyrin repeat-containing protein 1, KIAA0342, TRANK1, Lupus brain antigen 1 homolog

Data Image
References

The amyloid precursor protein and its derived fragments concomitantly contribute to the alterations of mitochondrial transport machinery in Alzheimer's disease., PMID:38806484

Transcriptomic and proteomic study of cancer cell lines exposed to actinomycin D and nutlin-3a reveals numerous, novel candidates for p53-regulated genes., PMID:38460933

Sleep Disorder Kleine-Levin Syndrome (KLS) Joins the List of Polygenic Brain Disorders Associated with Obstetric Complications., PMID:37553546

Mapping brain gene coexpression in daytime transcriptomes unveils diurnal molecular networks and deciphers perturbation gene signatures., PMID:36265442

New Evidence of Gut Microbiota Involvement in the Neuropathogenesis of Bipolar Depression by TRANK1 Modulation: Joint Clinical and Animal Data., PMID:34992606

Impaired blood-brain barrier in the microbiota-gut-brain axis: Potential role of bipolar susceptibility gene TRANK1., PMID:34014031

Regulation of TRANK1 by GSK-3 in the brain: unexpected interactions., PMID:33931729

Kleine-Levin syndrome is associated with birth difficulties and genetic variants in the TRANK1 gene loci., PMID:33737391

Independent replications and integrative analyses confirm TRANK1 as a susceptibility gene for bipolar disorder., PMID:32791513

Exome sequencing identification of susceptibility genes in Chinese patients with keratoconus., PMID:32744102

Anti-TSNARE1 IgG plasma levels differ by sex in patients with schizophrenia in a Chinese population., PMID:31336035

Sodium valproate rescues expression of TRANK1 in iPSC-derived neural cells that carry a genetic variant associated with serious mental illness., PMID:30135510

Genetic Variants Involved in Bipolar Disorder, a Rough Road Ahead., PMID:29541150

Study of Novel Autoantibodies in Schizophrenia., PMID:29373732

A genome-wide association study identifies two novel susceptibility loci and trans population polygenicity associated with bipolar disorder., PMID:28115744

Characterization of type I interferon pathway during hepatic differentiation of human pluripotent stem cells and hepatitis C virus infection., PMID:26313525

Genome-wide association study reveals two new risk loci for bipolar disorder., PMID:24618891

Polygenic dissection of diagnosis and clinical dimensions of bipolar disorder and schizophrenia., PMID:24280982

The major vault protein mediates resistance to epidermal growth factor receptor inhibition in human hepatoma cells., PMID:22261339

Genome-wide association study meta-analysis of European and Asian-ancestry samples identifies three novel loci associated with bipolar disorder., PMID:22182935

TRANK, a novel cytokine that activates NF-kappa B and c-Jun N-terminal kinase., PMID:9647199

Datasheet
$ 330
Product specifications
100 μg 330 1 mg 1880

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Recombinant Human TRANK1 Protein, C-His [YHA39401]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only